Otsuka grows Pocari overseas while searching for its next medicines
70.6%FY2025 overseas share of Nutraceutical revenue
−22.5%FY2025 change in JINARC/JYNARQUE revenue
¥334.5bnFY2025 Pharmaceutical Business R&D expenses
What emerges
See the company through the numbers →Otsuka combines local production and supplies from existing overseas factories to expand its consumer products. Its Pharmaceutical Business must develop future medicines while existing products face the end of exclusivity. Medical knowledge has also contributed to Pocari Sweat and Calorie Mate. The connections sit alongside distinct manufacturing, selling and research work for each product.